MICRONEEDLING VERSUS ADAPALENE GEL IN THE MANAGEMENT OF FACIAL PLANE WARTS: A HEAD TO HEAD CLINICAL TRIAL
DOI:
https://doi.org/10.55519/JAMC-04-13120Abstract
Background: Development of Plane warts (verruca plana) on face is not uncommon and warrants treatment due to its unsightly appearance. A number of treatment options have been explored till date exhibiting variable efficacy. Adapalene gel is a 3rd generation retinoid that upon application onto the surface of skin can result in clearance of warts. Microneedling, a procedure in which skin is pricked with needles via a device recently gain popularity as it is utilized for a number of dermatological procedures including acne scars, alopecia, vitiligo and for skin rejuvenation. It is hypothesized that the resultant injury induces immune response that can result in clearance of warts. Lack of head-to-head clinical trials comparing the efficacy of microneedling and topical adapalene Gel for treatment of cutaneous warts compelled us to design this clinical research. Objective was to compare the efficacy of microneedling versus Adapalene gel in treatment of facial plane warts. Methods: The research commenced with the assent from hospitals ethical review committee. Clinical diagnosis of plane warts was done and then the study participants were recruited. This clinical trial was managed at Lady reading hospital, Peshawar from January 2022 to December, 2022. Block randomization was utilized to allocate 100 study participants, equally into group A and group B. Patients gave a written consent and were warned about the possible adverse events. Microneedling was performed on the participants in group A while the other group was advised to apply topical adapalene gel daily onto the surface of warts at night. A total of three microneedling sessions were done i.e. one session every four weeks. Clinical assessment was done monthly and the final evaluation was done after 4 months of initiating of treatment. The intervention was considered successful if all the warts resolved completely. Monthly follow up for a total of 6 months was done to document the recurrences. Results: Twenty-nine (58%) study subjects from group A had complete resolution of lesions. In group B, 22 (44%) participants exhibited complete remission. p=0.1614. Partial response was appreciated in 7 (14%) participants that were treated with Microneedling procedure and 8 (16%) patients from adapalene treated group showed partial improvement. Conclusion: Both Topical adapalene and microneedling are effective in treating facial plane warts.
References
1. Essa N, Saleh MA, Mostafa RM, Taha EA, Ismail TA. Prevalence and factors associated with warts in primary school children in Tema District, Sohag Governorate, Egypt. J Egypt Public Health Assoc 2019;94(1):6–7.
2. Redzic N, Pereira AR, Menon S, Bogers J, Coppens A, Kehoe K, et al. Characterization of type-specific HPV prevalence in a population of persistent cutaneous warts in Flanders, Belgium. Sci Rep 2023;13(1):17492.
3. Ghadgepatil SS, Gupta S, Sharma YK. Clinicoepidemiological Study of Different Types of Warts. Dermatol Res Practice 2016;2016(2):7989817.
4. Truong K, Joseph J, Manago B, Wain T. Destructive therapies for cutaneous warts: A review of the evidence. Aust J Gen Pract 2022;51(10):799–803.
5. Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. Br J Dermatol 2014;171(4):696–712.
6. Le M, Conte S, Hsu JTS, Li MK. Energy-Based Devices for the Treatment of Cutaneous Verrucae: A Systematic Review. Dermatol Surg 2024;50(4):345–53.
7. Sivasankari M, Adityan MS. Oral isotretinoin as first-line systemic therapy in a case of extensive genital warts. Indian J Sex Transm Dis AIDS 2022;43(1):70–2.
8. Gupta M. Adapalene in the Management of Warts in Pediatric Population. Indian J Paediatr Dermatol 2019;20(1):29–31.
9. De Vita V, Goldust M. Efficacy and Safety of Microneedling for the Treatment of Cutaneous Warts. Hand (N Y) 2019;14(5):705–6.
10. Oren‐Shabtai M, Snast I, Noyman Y, Lapidoth M, Sherman S, Mimouni D, et al. Topical and systemic retinoids for the treatment of cutaneous viral warts: A systematic review and meta‐analysis. Dermatol Ther 2021;34(1):e14637.
11. Gupta R. Plantar warts treated with topical adapalene. Indian J Dermatol 2011;56(5):513–4.
12. Gupta R, Gupta S. Topical adapalene in the treatment of plantar warts; Randomized comparative open trial in comparison with cryo-therapy. Indian J Dermatol 2015;60(1):102.
13. Mahboob M, Ahmed N, Rahman A, Naz K, Niaz F, Farooq O. Comparison of topical 0.1% adapalene gel versus cryotherapy in patients with plantar warts. J Ayub Med Coll Abbottabad 2022;34(3):417–21.
14. Kubeyinje EP. Evaluation of the efficacy and safety of 0.05% tretinoin cream in the treatment of plane warts in Arab children. J Dermatol Treat 1996;7(1):21–2.
15. Ghonemy S, Ibrahim Ali M, Ebrahim HM. The efficacy of microneedling alone vs its combination with 5-fluorouracil solution vs 5-fluorouracil intralesional injection in the treatment of plantar warts. Dermatol Ther 2020;33(6):e14179.
16. Ali AA, Darwish HM, Galal SA. Comparative study between microneedling alone and microneedling followed by topical bleomycin or topical green tea extract (polyphenone E) in treatment of plantar warts. Sci J Al-Azhar Med Fac Girls 2021;5(3):651–60.
17. Zhang Y, Jiang JS, Kuai L, Luo Y, Chen JL, Wang YJ, et al. Efficacy and Safety of Fire Needle Therapy for Flat Warts: Evidence from 29 Randomized Controlled Trials. Evid Based Complement Alternat Med 2021;221:9513762.
18. Cunningham DJ, Brimage JT, Naraghi RN, Bower VM. Needling versus liquid nitrogen cryotherapy for the treatment of pedal warts a randomized controlled pilot study. J Am Podiatr Med Assoc 2014;104(4):394–401.
19. Kumari P, Yadav D, Vijay A, Jain SK, Kumar M, Kumar R et al. Falknor's needling method as a potential immunotherapy in palmo-plantar warts. Indian J Dermatol Venereol Leprol 2019;85(1):129
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jahangir Khan, Huma Gul
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
